Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors. 2014

Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
Scientific Veterinary Institute Novi Sad, Novi Sad, Serbia. tomy@niv.ns.ac.rs.

BACKGROUND Hepatitis E virus (HEV) infection is rarely reported in industrialized countries, but recent studies have revealed quite variable seroprevalence rates among European populations, including blood donors. In Serbia, very limited data about HEV seroprevalence are available. This study aimed to determine the prevalence of anti-HEV IgG antibodies and HEV RNA in the sera of volunteer blood donors in Serbia. METHODS Serum samples from 200 volunteer blood donors were tested for the presence of anti-HEV IgG by enzyme-linked immunosorbent assay (ELISA) using ORF-2 HEV genotype 3 recombinant proteins as antigen, and for the presence of HEV RNA by nested reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS In total, 15% of the volunteer blood donors were seropositive. The prevalence increased with age; 21.5%, 14.2%, and 5.4% HEV seroprevalence rates were found in individuals older than 51 years, between 31 and 50 years, and in those younger than 30 years of age, respectively. However, no HEV RNA was detected in any of the individuals analyzed. CONCLUSIONS The prevalence of anti-HEV IgG among blood donors as representatives of the general population is quite high in Serbia compared to data from many European countries. One of the reasons for this could be the high prevalence of HEV among Serbian pigs and the traditional consumption of piglet meat in the country. The relatively high HEV seroprevalence found among Serbian blood donors indicates the need for further investigation.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
June 2016, Food and environmental virology,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
June 2007, Journal of clinical microbiology,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
November 2010, Enfermedades infecciosas y microbiologia clinica,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
September 2022, Journal of hepatology,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
December 2011, Emerging infectious diseases,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
October 2023, Viruses,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
October 2019, Journal of viral hepatitis,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
February 2016, Journal of medical virology,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
February 2018, The New Zealand medical journal,
Tamaš Petrović, and Diana Lupulović, and Nereida Jiménez de Oya, and Svetlana Vojvodić, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Miguel A Martín-Acebes, and Aleksandar Potkonjak, and Vesna Milošević, and Sava Lazić, and Juan-Carlos Saiz
August 2004, Journal of medical virology,
Copied contents to your clipboard!